Mikkel has great technical expertise, a strategic mindset and experience building global cost-effectiveness models. He uses all of this to help our clients demonstrate product value and communicate it to key stakeholders. Mikkel brings years of experience with high-quality evidence generation to supports the clients' value strategies.
His expertise lies in the intersection between evidence generation and health economic modelling, where he applies his competencies within statistical analysis of clinical trial data, indirect treatment comparison (network meta-analysis (NMA), matching adjusted indirect comparison (MAIC), Bucher analysis) and real-world evidence as basis for the development of global cost-effectiveness models for HTA submissions and P&R dossiers for European markets.
Mikkel excels in the ability to put himself in the client’s shoes in order to deliver a product that creates great value.